Have a personal or library account? Click to login
The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures Cover

The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures

Open Access
|Oct 2017

References

  1. 1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarwis WR: Guideline for prevention of surgical site infection, 1999. Centers for Disease Contyrol and Prevention (CDC) Hospital infection control practices advisory committee, Am J Infect Control 1999; 27:97-132
  2. 2. Jiang X, Ma J, Hou F, Li J, Li R, Lang H: Neurosurgical site infection prevention: Single institute experience, Turk Neurosurg 2016; 26(2):234-239
  3. 3. Inigo JJ, Bermejo B, Oronoz B, Herrera J, Tarifa A, Perez F, Miranda C, Lera JM: Surgical site infection in general surgery: 5-yaer analysis and assessment of the National Nosocomial Infection Surveillance (NNIS) index, Cir Esp 2006; 79:224-23010.1016/S0009-739X(06)70857-0
  4. 4. Kasatpibal N, Norgaard M, Jamulitrat SW: Improving surveillance system and surgical site infection rates through a network: A pilot study from Thailand, Clin Epidemiol 2009; 1:67-7410.2147/CLEP.S5507
  5. 5. Waits SA, Fritze D, Banerjee M, Zhang W, Kubus J, Englesbe MJ, Campbell DA Jr, Hendren S: Developing an argument for bundled interventions to reduce surgical site infection in colorectal surgery, Surgery 2014; 155:602-60610.1016/j.surg.2013.12.00424468041
  6. 6. Ward VP, Charlett A, Fagan J, Crawshaw SC: Enhanced surgical site infection surveillance following caesarean section: Experience of a multicenter collaborative post-discharge system, J Hosp Infect 2008; 70:166-17310.1016/j.jhin.2008.06.00218723248
  7. 7. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, Lamping DL, Krukowski ZH, Reeves BC: Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection, Health Technol Assess 2011; 15:1-15610.3310/hta1530021884656
  8. 8. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS: Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System basic SSI risk index, Clin Infect Dis 2001; 33(Suppl 2):S69-7710.1086/32186011486302
  9. 9. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM: The efficacy of infection surveillance and control programs in in preventing nosocomial infections in US hospitals, Am J Epidemiol 1985; 121:182-20510.1093/oxfordjournals.aje.a1139904014115
  10. 10. Geubbels EL, Nagelkerke NJ, Mintjes-De Groot AJ, Vandenbroucke-Grauls CM, Grobbee DE, De Boer AS: Reduced riski of msurgical site infections through surveillance in a network, Int J Qual Health Care 2006; 18:127-13310.1093/intqhc/mzi10316484315
  11. 11. Healey MA, Shackford SR, Osler TM, Rogers FB, Burns E: Complications in surgical patients, Arch Surg 2002; 137:611-61710.1001/archsurg.137.5.61111982478
  12. 12. Buang SS, Haspani MS: Risk factors for neurosurgical site infection after a neurosurgical procedure: A prospective observational study at Hospital Kuala Lumpur, Med J Malaysia 2012; 67(4):393-8
  13. 13. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: A prospective study of risk factors, J Neurosurg 2001; 94(2):195-20110.3171/jns.2001.94.2.019511213954
  14. 14. Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G: Surgical site infection after elective neurosurgery: A survey of 1747 patients, Neurosurgery 2009; 62(1):88-9510.1227/01.NEU.0000311065.95496.C5
  15. 15. Haines SJ:: Efficacy of antibiotic prophylaxis in clean neurosurgical operations, Neurosurgery 1989; 24:401-40510.1227/00006123-198903000-00016
  16. 16. Borges ES, Machado Ferreira SC: Relevant actions in the control of surgical site infections in neurosurgery: An integrative review, OBJN 2016; 15(4):1-9
  17. 17. World Health Organization (SWZ): WHO guidelines for safe surgery, 2009, Geneva: WHO
  18. 18. Owens CD, Stoessel K: Surgical site infections: epidemiology, microbiology and prevention, J Hosp Infect 2008; 70(S2):3-1010.1016/S0195-6701(08)60017-1
  19. 19. Edwards JR, Peterson BBA, Banerjee S, Allen-Bridson K, Morrell G, Margaret A: National Health Safety Network (NHSN) Report, data summary for 2006 through 2007, Am J Infect Control 2008; 36:609-2610.1016/j.ajic.2008.08.001
  20. 20. Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS: Costs associated with surgical site infections in Veterans affairs hospitals, JAMA Surg 2014; 149(6):575-8110.1001/jamasurg.2013.4663
  21. 21. Kaye KS, Schmit K, Pieper C, Sloane R, Caughlan KF, Sexton DJ, Schmader KE: The effect of increasing age on the risk factor of surgical site infection, J Infect Dis 2005; 191:1056-6210.1086/428626
  22. 22. Cruse PJ: Wound infection surveillance, Rev Infect Dis 1981; 4(3):734-4710.1093/clinids/3.4.734
  23. 23. Vegas AA, Garcia ML: Nosocomial infection in surgery wards: A controlled study of increased duration of hospital stays and direct cost of hospitalization, Eur J Epidemiol 1993; 9(5):504-10.10.1007/BF00209528
  24. 24. Nishant, Kailash KK, Vijayraghavan PV: Prospective randomized study for antibiotic prophilaxis in spine surgery: Choice of drug, dosage and timing, Asian Spine J 2013; 7(3):196-20310.4184/asj.2013.7.3.196
  25. 25. Holloway KL, Smith KW, Wilberger J, Collins JJ: Antibiotic prophylaxis during clean neurosusrgery: A large, multicenter study using cefuroxime, Clin Ther 1996; 18(1):84-9410.1016/S0149-2918(96)80181-0
  26. 26. Malomo AO, Adeolu AA, Odebode TO, Komolafe EO, Shokunbi MT: Prospective comparative trial of ceftriaxone versus ceftazidime as prophylactic perioperative antimicrobials in neurosurgery, ECA J Surg 2007; 12(1):89-92
  27. 27. Zhao JZ, Wang S, Li JS, Yang J, Zang JT, He Q, Shao LL, Dai ZX, Chao XY, Lau KC: The perioperative use of ceftriaxone as infection prophylaxis in neurosurgery, Clin Neurol Neurosurg 1995; 97(4):285-910.1016/0303-8467(95)00054-N
  28. 28. Zhu XL, Wong WK, Yeung WM, Mo P, Tsang CS, Pang KH, Po YC, Aung TH: A randomized, double-blind comparison of ampicillin/sulbactam and ceftriaxone in the prevention of surgical-site infections after neurosurgery, Clin Ther 2001; 23(8):1281-9110.1016/S0149-2918(01)80107-7
  29. 29. Arnaboldi L: Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures, Chemother 1996; 42(5):384-39010.1159/0002394708874978
  30. 30. Bodzinski J, Barczewska M, Marchel A: Ceftriaxone in short-term program of perioperational prophylaxis in neurosurgery, Neurol Neurochir Pol 1993; 27(1):55-61
  31. 31. Barker II FG: Efficacy of prophylactic antibiotic for craniotomy: A meta-analysis, Neurosurgery 1994; 35(3):484-9210.1227/00006123-199409000-000177646627
  32. 32. Bullock R, van Dellen JR, Ketelbey W: A double-blind placebo-controlled trial of perioperative prophylactic antibiotics for elective neurosurgery, J Neurosurg 1988; 69(5):687-9110.3171/jns.1988.69.5.06873054011
  33. 33. Dempsey R, Rapp RP, Young B: Prophylactic parenteral antibiotics in clean neurosurgical procedures: A review, J Neurosurg 1988; 69:52-710.3171/jns.1988.69.1.00523288725
  34. 34. Djindjian M: Antibiotic prophylaxis in neurosurgery, Ann Fr Anesth Reanim 1994; 13:93-5
  35. 35. Petrica A, Ionac M, Brinzeu C, Brinzeu A: Surgical site infections surveillance in neurosurgery patients, Tim Med J 2009; 3-4:1-4
  36. 36. Altemeier WA: Sepsis in neurosurgery. Presidential address, Arch Surg 1982; 117(2):107-12
  37. 37. Van Walraven C, Musselman R: The surgical site infection risk score (SSIRS): A model to predict the risk of surgical site infections, PLOS ONE 2013; 8(6):1-410.1371/journal.pone.0067167369497923826224
  38. 38. Bowater RJ, Stirling SA, Lilford RJ: Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses, Ann Surg 2009; 249:551-610.1097/SLA.0b013e318199f20219300236
  39. 39. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J: Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection, Health Technol Assess 2011; 15:1-iv10.3310/hta1530021884656
  40. 40. Korinek AM: Risk factors for neurosurgical site infections after craniotomy: A prospective multicenter study of 2944 patients. The French study group of neurosurgical infections, the SEHP, and the C-CLIN Paris-Nord service epidemiologie hygiene et prevention. Neurosurgery 1997; 41(5):1073-8110.1097/00006123-199711000-000109361061
  41. 41. Margaret AO, Jennie M, Carl L: Risk factors for surgical site infection in spinal surgery, J Neurosurg (Spine 2) 2003; 98:149-5510.3171/spi.2003.98.2.0149
  42. 42. Heymsfield SB, Wadden TA: Mechanisms, pathophysiology and management of obesity, N Engl J Med 2017; 376(3):254-6610.1056/NEJMra1514009
  43. 43. Fry DE: Surgical site infection: Pathogenesis and prevention. CME Program. Medscape from WebMD 2003
  44. 44. Leape LL, Brennan TA, Laird N: The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324 (6):377-38410.1056/NEJM199102073240605
  45. 45. Nathens AB, Cook CH, Machiedo G, Moore EE, Namias N, Nwariaku F: Defining the research agenda for surgical infection: A consensus of experts using the Delphi approach. Surg Infect 2006; 7(2):101-11010.1089/sur.2006.7.101
  46. 46. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ: The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20(11):725-73010.1086/501572
  47. 47. Barnard B: Prevention of surgical site infections. Infect Control Today 2003; 71(4):57-60
  48. 48. Savitz MH, Katz SS: Rationale for prophylactic antibiotics and neurosurgery. Neurosurgery 1981; 9:142-410.1227/00006123-198108000-00005
  49. 49. Stall AC, Becker E, Ludwig SC et al.: Reduction of postoperative spinal implant infection using gentamicin microspheres, Spine 2009; 34(5):479-8310.1097/BRS.0b013e318197e96c
  50. 50. Hanssen AD, Osmon DR, Patel R: Local antibiotic delivery systems: Where are we and where are we going? Clin Orthop Relat Res 2005; 437:111-410.1097/01.blo.0000175122.50804.ce
  51. 51. O’Neill KR, Smith JG, Abtahi AM, Archer KR, Spengler DM, McGirt MJ, Devin CJ: Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder, Spine J 2011; 11:641-64610.1016/j.spinee.2011.04.025
  52. 52. McClelland III S, Hall W: Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures, CID 2007; 45:55-910.1086/518580
  53. 53. Borges LF: Infections in neurologic suregery: Host defenses, Neurosurg Clin N Am 1992; 3:275-810.1016/S1042-3680(18)30661-2
  54. 54. Korinek AM, Baugnon T, Golmard JL, van Effenterre R, Coriat P, Puybasset L: Risk factors for adult nosocomial meningitis after craniotomy: Role of antibiotic prophylaxis, Neurosurgery 2006; 59:126-3310.1227/01.NEU.0000220477.47323.9216823308
  55. 55. Mollman HD, Haines SJ: Risk factors for postoperative neurosurgical wound infection: A case-control study, J Neurosurg 1986; 64:902-610.3171/jns.1986.64.6.09023701440
DOI: https://doi.org/10.1515/prilozi-2017-0026 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Language: English
Page range: 85 - 97
Published on: Oct 7, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2017 Aleksandra Dimovska-Gavrilovska, Aleksandar Chaparoski, Andreja Gavrilovski, Zvonko Milenkovikj, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.